Atlas Trials

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

Clinical trial NCT03521791 · COMPLETED

Trial details

NCT number
NCT03521791
Sponsor
Laboratorios Sophia S.A de C.V.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
PterygiumOcular PainOcular InflammationPost-surgical Inflammation
Start date
2017-12-13
Primary completion
2018-09-14
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.